Access the Yankees beat like never before

Join Post Sports+ for exciting subscriber-only features, including real-time texting with Greg Joyce about the inside buzz on the Yankees.

TAMPA — The Yankees are not yet at the point of “last resort” with Giancarlo Stanton’s elbows.

But when he might be available to the Yankees, or even resume baseball activities, remains very much in question.

The veteran DH received a second round of PRP injections on his elbows Thursday, general manager Brian Cashman said, treating the tennis elbow (tendinitis) that has ailed him in both arms since before he arrived at spring training and will put him on the injured list to begin the season.

It remains to be seen when Stanton will pick up a bat again — it has been five-plus weeks since he last swung one — but for now, the Yankees are trying to treat his elbows conservatively before they would have to consider alternatives like surgery.

“It’d be a last resort,” Cashman said Thursday at Steinbrenner Field. “I can’t rule out a surgery, but I know it’s not recommended in the front end of this thing. But obviously if you have a number of different failed attempts, then you start looking at different ways of intervention.”

Stanton, who has been back in New York to tend to a personal matter for the past week and a half but is expected to return to Tampa this weekend, played through the elbow issues for most of last season, including his monster playoff run.

But it flared back up as the 35-year-old prepared for camp, leaving the Yankees in the conundrum they are now.

Cashman said Stanton did not get the PRP injections over the offseason because his complaints about the elbow did not come up until shortly before camp.

“Obviously [we] thought we were in a good place and I think he was feeling in a good place, but then it reared its ugly head three weeks before camp, is my understanding,” Cashman said. “Now we’re dealing with it. Give it the time it needs and we’ll clearly look forward to getting him back, but obviously in the near term that won’t be the case.”

For now, Stanton is out indefinitely as the Yankees wait for his elbow pain to subside.

But there is no guarantee that the PRP injections will solve the issue, as the club previously acknowledged that whenever Stanton does return to playing, he will likely have to continue managing the elbows.

“The PRP injections are designed to help the healing process,” Cashman said. “You hope that’s the case. But A, you have to let it take, and B, you have to let it play out and then hopefully you get a positive resolution. Like in most things — unless it’s a hamstring or stuff like that — you’re in a little bit of the unknown and you’re trying to treat everything conservatively and you hope for the best. But you have to give it the time to play out first until you know where you’re sitting.”

In the meantime, the Yankees will likely cycle through a number of internal options to fill the DH spot while Stanton is out.

That will include occasional days for Aaron Judge, which would bump Trent Grisham into the lineup in center field, with Cody Bellinger switching to right.

The Yankees could also decide to carry three catchers, which could mean DH at-bats for Ben Rice and/or J.C. Escarra, both left-handed hitters.

Ex-Met Dom Smith has also had a strong start to camp, but he is another left-handed hitter and is not on the 40-man roster.

Manager Aaron Boone has raved this spring about Everson Pereira, a right-handed hitting outfielder, but he is coming back from Tommy John surgery and isn’t expected to play the field until mid-March.

It remains to be seen whether the Yankees would want to give him time to fully ramp up in the outfield — which would likely happen at Triple-A — or carry him as a DH.

“I like where Ben Rice is at, I think Ben can really hit,” Boone said Thursday. “J.C. Escarra we think can really hit. Dom’s come in here and looked really strong. I like what I’m seeing from Everson Pereira. So we’ll see. We got a few weeks before we get there and then it keeps evolving from there. We’ll see what our final roster looks like, but I like the in-house candidates, especially against right-handed pitching that we’ll be able to weather that storm.”